Table 5.
Risk of elevated intraocular pressure
| Study | Test intervention | No. with outcome/No. in group | Control intervention | No. with outcome | Total No./No. with outcome |
|---|---|---|---|---|---|
| Aminocaproic acid | |||||
| Kraft 1987 | Oral aminocaproic acid | 1/24 | Placebo | 1/25 | 2/49 |
| Kutner 1987 | Oral aminocaproic acid | 1/21 | Placebo | 3/13 | 4/34 |
| Teboul 1995 | Oral aminocaproic acid | 3/48 | Placebo | 3/46 | 6/94 |
| Pieramici 2003 | Topical aminocaproic acid | 2/24 | Placebo | 1/27 | 3/51 |
| Palmer 1986 | Standard-dose oral aminocaproic acid | 2/33 | Low-dose oral aminocaproic acid | 0/26 | 2/59 |
| Tranexamic acid | |||||
| Vangsted 1983 | Tranexamic acid | 8/59 | Bed rest only | 6/53 | 14/112 |
| Varnek 1980 | Tranexamic acid | 8/102 | Conservative treatment | 7/130 | 15/232 |
| Rahmani 1999 | Tranexamic acid | 12/80 | Placebo | 12/80 | 24/160 |
| Welsh 1983 | Tranexamic acid | 1/19 | Placebo | 2/20 | 3/39 |
| Prednisone/cortisone | |||||
| Spoor 1980 | Oral prednisone | 0/23 | Placebo | 0/20 | 0/43 |
| Rahmani 1999 | Oral prednisone | 9/78 | Placebo | 12/80 | 21/158 |
| Zetterstrom 1969 | Atropine plus cortisone eyedrops | 3/58 | Conservative treatment | 2/59 | 5/117 |
| Nondrug medical interventions | |||||
| Edwards 1973 | Monocular patching | 3/35 | Binocular patching | 0/29 | 3/64 |
| Read 1974 | Ambulation | 17/71 | Bed rest | 19/66 | 36/137 |
| Zi 1999 | Laying on right and left lateral position | 7/39 | Laying in semi-reclining position | 8/35 | 15/74 |
NR: not reported.